Versor Investments LP Cuts Holdings in Colgate-Palmolive (NYSE:CL)

Versor Investments LP reduced its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 34.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,095 shares of the company's stock after selling 3,662 shares during the period. Versor Investments LP's holdings in Colgate-Palmolive were worth $645,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in CL. FMR LLC lifted its holdings in shares of Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company's stock valued at $700,642,000 after buying an additional 2,674,807 shares during the period. Barclays PLC lifted its stake in shares of Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company's stock valued at $793,542,000 after purchasing an additional 2,132,747 shares during the period. State Street Corp boosted its holdings in Colgate-Palmolive by 3.8% during the third quarter. State Street Corp now owns 48,436,276 shares of the company's stock worth $5,028,170,000 after buying an additional 1,784,411 shares in the last quarter. Nordea Investment Management AB grew its position in Colgate-Palmolive by 32.5% during the fourth quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company's stock valued at $462,121,000 after buying an additional 1,247,731 shares during the period. Finally, AustralianSuper Pty Ltd increased its holdings in Colgate-Palmolive by 941.9% in the fourth quarter. AustralianSuper Pty Ltd now owns 1,138,655 shares of the company's stock valued at $103,515,000 after buying an additional 1,029,364 shares in the last quarter. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Trading Down 1.0 %

NYSE:CL traded down $0.90 during trading hours on Tuesday, reaching $91.91. 3,528,398 shares of the stock were exchanged, compared to its average volume of 4,836,143. Colgate-Palmolive has a twelve month low of $85.32 and a twelve month high of $109.30. The business has a 50-day moving average of $88.76 and a two-hundred day moving average of $95.37. The company has a market capitalization of $74.59 billion, a price-to-earnings ratio of 26.11, a PEG ratio of 4.20 and a beta of 0.44. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter last year, the business posted $0.87 EPS. On average, equities analysts predict that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.18%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive's payout ratio is currently 56.82%.

Wall Street Analysts Forecast Growth

Several analysts have commented on CL shares. Piper Sandler cut their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research report on Monday, January 6th. Barclays cut their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a report on Friday, January 17th. StockNews.com raised shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a report on Monday. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an "underweight" rating on the stock in a report on Tuesday, January 7th. Finally, TD Cowen reduced their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating for the company in a research report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $101.61.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.